Latanoprost Solution
Product Images NDC 59762-0333

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Latanoprost (NDC 59762-0333). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Latanoprost 01)

FDA Label Image

Logo (Latanoprost 02)

Logo (Latanoprost 02)
The Greenstone Brand is distributed by Greenstone LLC located in Peapack, NJ 07977.*
FDA Label Image

Principal Display Panel (125 mcg/2.5 mL)

Principal Display Panel (125 mcg/2.5 mL)
This is a medication information for Latanoprost Ophthalmic Solution. It's a sterile solution with 0.005% concentration and contains 125 micrograms per 2.5mL. The usual dosage is 1 drop in the affected eye(s) in the evening. It is distributed by Greenstone LLC and based in Peapack, NJ.*
FDA Label Image

Principal Display Panel (125 mcg/2.5 mL)

Principal Display Panel (125 mcg/2.5 mL)
This is a prescription label for a 2.5 mL bottle of latanoprost ophthalmic (eye) solution, which contains 50 micrograms of latanoprost and is used for refrigeration at 2-8°C (46°F-46°F). The solution is distributed by PAATG1400 and the prescription label warns to keep it out of reach of children, although it is not child-resistant. The label also provides important storage information for mail-order patients who may store opened bottles at room temperature for up to 6 weeks. The GTIN is 003597620 and the dosage is 125 meg/2.5mL.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.